A citation-based method for searching scientific literature

Chiara Fabbri, Joseph Zohar, Alessandro Serretti. Prog Neuropsychopharmacol Biol Psychiatry 2018
Times Cited: 26







List of co-cited articles
146 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled study.
John F Greden, Sagar V Parikh, Anthony J Rothschild, Michael E Thase, Boadie W Dunlop, Charles DeBattista, Charles R Conway, Brent P Forester, Francis M Mondimore, Richard C Shelton,[...]. J Psychiatr Res 2019
87
42

Contribution of common genetic variants to antidepressant response.
Katherine E Tansey, Michel Guipponi, Xiaolan Hu, Enrico Domenici, Glyn Lewis, Alain Malafosse, Jens R Wendland, Cathryn M Lewis, Peter McGuffin, Rudolf Uher. Biol Psychiatry 2013
117
38

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors.
J K Hicks, J R Bishop, K Sangkuhl, D J Müller, Y Ji, S G Leckband, J S Leeder, R L Graham, D L Chiulli, A LLerena,[...]. Clin Pharmacol Ther 2015
412
38

Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update.
J K Hicks, K Sangkuhl, J J Swen, V L Ellingrod, D J Müller, K Shimoda, J R Bishop, E D Kharasch, T C Skaar, A Gaedigk,[...]. Clin Pharmacol Ther 2017
216
34


Pharmacogenetic tests and depressive symptom remission: a meta-analysis of randomized controlled trials.
Chad A Bousman, Katarina Arandjelovic, Serafino G Mancuso, Harris A Eyre, Boadie W Dunlop. Pharmacogenomics 2019
63
30

A prospective, randomized, double-blind study assessing the clinical impact of integrated pharmacogenomic testing for major depressive disorder.
Joel G Winner, Joseph M Carhart, C Anthony Altar, Josiah D Allen, Bryan M Dechairo. Discov Med 2013
107
26

Efficacy of prospective pharmacogenetic testing in the treatment of major depressive disorder: results of a randomized, double-blind clinical trial.
Víctor Pérez, Ariana Salavert, Jordi Espadaler, Miquel Tuson, Jerónimo Saiz-Ruiz, Cristina Sáez-Navarro, Julio Bobes, Enrique Baca-García, Eduard Vieta, José M Olivares,[...]. BMC Psychiatry 2017
81
26

Genetic polymorphisms of cytochrome P450 enzymes and antidepressant metabolism.
Stefano Porcelli, Chiara Fabbri, Edoardo Spina, Alessandro Serretti, Diana De Ronchi. Expert Opin Drug Metab Toxicol 2011
49
26

Improved efficacy with targeted pharmacogenetic-guided treatment of patients with depression and anxiety: A randomized clinical trial demonstrating clinical utility.
Paul Bradley, Michael Shiekh, Vishaal Mehra, Keith Vrbicky, Stacey Layle, Marilyn C Olson, Alejandra Maciel, Ali Cullors, Jorge A Garces, Andrew A Lukowiak. J Psychiatr Res 2018
64
23





Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.
Madhukar H Trivedi, A John Rush, Stephen R Wisniewski, Andrew A Nierenberg, Diane Warden, Louise Ritz, Grayson Norquist, Robert H Howland, Barry Lebowitz, Patrick J McGrath,[...]. Am J Psychiatry 2006
23

Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments.
Sidney H Kennedy, Raymond W Lam, Roger S McIntyre, S Valérie Tourjman, Venkat Bhat, Pierre Blier, Mehrul Hasnain, Fabrice Jollant, Anthony J Levitt, Glenda M MacQueen,[...]. Can J Psychiatry 2016
363
23

Commercial pharmacogenetic-based decision-support tools in psychiatry.
Chad A Bousman, Malcolm Hopwood. Lancet Psychiatry 2016
64
19

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.
A John Rush, Madhukar H Trivedi, Stephen R Wisniewski, Andrew A Nierenberg, Jonathan W Stewart, Diane Warden, George Niederehe, Michael E Thase, Philip W Lavori, Barry D Lebowitz,[...]. Am J Psychiatry 2006
19

Effect of cytochrome CYP2C19 metabolizing activity on antidepressant response and side effects: Meta-analysis of data from genome-wide association studies.
Chiara Fabbri, Katherine E Tansey, Roy H Perlis, Joanna Hauser, Neven Henigsberg, Wolfgang Maier, Ole Mors, Anna Placentino, Marcella Rietschel, Daniel Souery,[...]. Eur Neuropsychopharmacol 2018
25
20

Towards the integration of pharmacogenetics in psychiatry: a minimum, evidence-based genetic testing panel.
Chad Bousman, Abdullah Al Maruf, Daniel J Müller. Curr Opin Psychiatry 2019
30
19

Pharmacogenetics of antidepressant response: A polygenic approach.
Judit García-González, Katherine E Tansey, Joanna Hauser, Neven Henigsberg, Wolfgang Maier, Ole Mors, Anna Placentino, Marcella Rietschel, Daniel Souery, Tina Žagar,[...]. Prog Neuropsychopharmacol Biol Psychiatry 2017
40
15

Clinical impact of pharmacogenetic profiling with a clinical decision support tool in polypharmacy home health patients: A prospective pilot randomized controlled trial.
Lindsay S Elliott, John C Henderson, Moni B Neradilek, Nicolas A Moyer, Kristine C Ashcraft, Ranjit K Thirumaran. PLoS One 2017
71
15

Genome-wide pharmacogenetics of antidepressant response in the GENDEP project.
Rudolf Uher, Nader Perroud, Mandy Y M Ng, Joanna Hauser, Neven Henigsberg, Wolfgang Maier, Ole Mors, Anna Placentino, Marcella Rietschel, Daniel Souery,[...]. Am J Psychiatry 2010
238
15

Pharmacogenetics in major depression: a comprehensive meta-analysis.
Tomihisa Niitsu, Chiara Fabbri, Francesco Bentini, Alessandro Serretti. Prog Neuropsychopharmacol Biol Psychiatry 2013
135
15

Physicians' opinions following pharmacogenetic testing for psychotropic medication.
Lucas M Walden, Eva J Brandl, Amtul Changasi, Jessica E Sturgess, Alexander Soibel, Janna Fe D Notario, Sheraz Cheema, Nicole Braganza, Victoria S Marshe, Natalie Freeman,[...]. Psychiatry Res 2015
30
15

Using a pharmacogenomic algorithm to guide the treatment of depression.
D K Hall-Flavin, J G Winner, J D Allen, J J Jordan, R S Nesheim, K A Snyder, M S Drews, L L Eisterhold, J M Biernacka, D A Mrazek. Transl Psychiatry 2012
116
15


Rapid evidence review of the comparative effectiveness, harms, and cost-effectiveness of pharmacogenomics-guided antidepressant treatment versus usual care for major depressive disorder.
Kimberly Peterson, Eric Dieperink, Johanna Anderson, Erin Boundy, Lauren Ferguson, Mark Helfand. Psychopharmacology (Berl) 2017
32
15

Utility of integrated pharmacogenomic testing to support the treatment of major depressive disorder in a psychiatric outpatient setting.
Daniel K Hall-Flavin, Joel G Winner, Josiah D Allen, Joseph M Carhart, Brian Proctor, Karen A Snyder, Maureen S Drews, Linda L Eisterhold, Jennifer Geske, David A Mrazek. Pharmacogenet Genomics 2013
118
15

Estimating cost savings of pharmacogenetic testing for depression in real-world clinical settings.
Alejandra Maciel, Ali Cullors, Andrew A Lukowiak, Jorge Garces. Neuropsychiatr Dis Treat 2018
21
19

A Pharmacogenomic-based Antidepressant Treatment for Patients with Major Depressive Disorder: Results from an 8-week, Randomized, Single-blinded Clinical Trial.
Changsu Han, Sheng-Min Wang, Won-Myong Bahk, Soo-Jung Lee, Ashwin A Patkar, Prakash S Masand, Laura Mandelli, Chi-Un Pae, Alessandro Serretti. Clin Psychopharmacol Neurosci 2018
14
28

Psychiatric pharmacogenomics predicts health resource utilization of outpatients with anxiety and depression.
J Winner, J D Allen, C Anthony Altar, A Spahic-Mihajlovic. Transl Psychiatry 2013
87
11


A Naturalistic Study of the Effectiveness of Pharmacogenetic Testing to Guide Treatment in Psychiatric Patients With Mood and Anxiety Disorders.
Francis X Brennan, Kathryn R Gardner, Jay Lombard, Roy H Perlis, Maurizio Fava, Herbert W Harris, Rachel Scott. Prim Care Companion CNS Disord 2015
27
11

The Innovative Canadian Pharmacogenomic Screening Initiative in Community Pharmacy (ICANPIC) study.
John Papastergiou, Peter Tolios, Wilson Li, Jane Li. J Am Pharm Assoc (2003) 2017
17
17

The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response.
J M Biernacka, K Sangkuhl, G Jenkins, R M Whaley, P Barman, A Batzler, R B Altman, V Arolt, J Brockmöller, C H Chen,[...]. Transl Psychiatry 2015
67
11




Clinical Implementation of Pharmacogenetic Decision Support Tools for Antidepressant Drug Prescribing.
Zane Zeier, Linda L Carpenter, Ned H Kalin, Carolyn I Rodriguez, William M McDonald, Alik S Widge, Charles B Nemeroff. Am J Psychiatry 2018
54
11

Misleading Guidance From Pharmacogenomic Testing.
Tahir Rahman, David M Ash, John Lauriello, Roshni Rawlani. Am J Psychiatry 2017
9
33

Clinical validity: Combinatorial pharmacogenomics predicts antidepressant responses and healthcare utilizations better than single gene phenotypes.
C A Altar, J M Carhart, J D Allen, D K Hall-Flavin, B M Dechairo, J G Winner. Pharmacogenomics J 2015
63
11

Pharmacogenetics of antidepressant drugs: an update after almost 20 years of research.
Chiara Fabbri, Giulia Di Girolamo, Alessandro Serretti. Am J Med Genet B Neuropsychiatr Genet 2013
56
11

The Routine Clinical use of Pharmacogenetic Tests: What it Will Require?
Mafalda M Dias, Michael J Sorich, Andrew Rowland, Michael D Wiese, Ross A McKinnon. Pharm Res 2017
10
30

No Support for Historical Candidate Gene or Candidate Gene-by-Interaction Hypotheses for Major Depression Across Multiple Large Samples.
Richard Border, Emma C Johnson, Luke M Evans, Andrew Smolen, Noah Berley, Patrick F Sullivan, Matthew C Keller. Am J Psychiatry 2019
164
11

Switching antidepressant class does not improve response or remission in treatment-resistant depression.
Daniel Souery, Alessandro Serretti, Raffaella Calati, Pierre Oswald, Isabelle Massat, Anastasios Konstantinidis, Sylvie Linotte, Joseph Bollen, Koen Demyttenaere, Siegfried Kasper,[...]. J Clin Psychopharmacol 2011
58
11

Comparison of the Guidelines of the Clinical Pharmacogenetics Implementation Consortium and the Dutch Pharmacogenetics Working Group.
P C D Bank, K E Caudle, J J Swen, R S Gammal, M Whirl-Carrillo, T E Klein, M V Relling, H-J Guchelaar. Clin Pharmacol Ther 2018
102
11


Cost-Effectiveness of a Pharmacogenetic Test to Guide Treatment for Major Depressive Disorder.
Erik J Groessl, Steven R Tally, Naomi Hillery, Alejandra Maciel, Jorge A Garces. J Manag Care Spec Pharm 2018
9
33



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.